Development of hepatic fibrosis occurs normally in AMPK-deficient mice

Clinical Science

Volumn 118, Issue 6, 2010, Pages 411-420

  da Silva Morais, Alain ^a   Abarca Quinones, Jorge ^a   Guigas, Bruno ^b,c   Viollet, Benoit ^d,e   Stärkel, Peter ^a   Horsmans, Yves ^a   Leclercq, Isabelle A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUT COCHIN   (France)

^e INSERM   (France)

Author keywords

5 amino 4 imidazolecarboxamide ribonucleotide (AICAR); AMP activated kinase (AMPK); Collagen; Fibrosis; Hepatic stellate cell; Transdifferentiation

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CARBON TETRACHLORIDE; COLLAGEN ALPHA1; COLLAGEN DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA3; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME STABILITY; FIBROGENESIS; GENE DELETION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REGULATOR GENE; UPREGULATION;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; FEMALE; HEPATIC STELLATE CELLS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MICE; RIBONUCLEOTIDES; RNA;

EID: 73149110119     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090293     Document Type: Article

References (34)

1. Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H. et al. (2003) Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125, 1796-1807
2. Ding, X., Saxena, N. K., Lin, S., Xu, A., Srinivasan, S. and Anania, F. A. (2005) The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am. J. Pathol. 166, 1655-1669
3. Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Scala, L., Zenari, L. and Falezza, G. (2006) Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin. Endocrinol. 64, 679-683
4. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T. et al. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332-339
5. Hardie, D. G. (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144, 5179-5183
6. Kahn, B. B., Alquier, T., Carling, D. and Hardie, D. G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25
7. Carling, D. (2005) AMP-activated protein kinase: balancing the scales. Biochimie 87, 87-91
8. Igata, M., Motoshima, H., Tsuruzoe, K., Kojima, K., Matsumura, T., Kondo, T., Taguchi, T., Nakamaru, K., Yano, M., Kukidome, D. et al. (2005) Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ. Res. 97, 837-844
9. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J. and Thompson, C. B. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-293
10. Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M. and Esumi, H. (2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287, 562-567
11. Caligiuri, A., Bertolani, C., Guerra, C. T., Aleffi, S., Galastri, S., Trappoliere, M., Vizzutti, F., Gelmini, S., Laffi, G., Pinzani, M. and Marra, F. (2008) Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology 47, 668-676
12. Adachi, M. and Brenner, D. A. (2008) High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology 47, 677-685
13. Jorgensen, S. B., Viollet, B., Andreelli, F., Frosig, C., Birk, J. B., Schjerling, P., Vaulont, S., Richter, E. A. and Wojtaszewski, J. F. (2004) Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 279, 1070-1079
14. Da Silva Morais, A., Abarca-Quinones, J., Horsmans, Y., Starkel, P. and Leclercq, I. A. (2007) Peroxisome proliferated-activated receptor ligand, pioglitazone, does not prevent hepatic fibrosis in mice. Int. J. Mol. Med. 19, 105-112
15. Leclercq, I. A., Farrell, G. C., Schriemer, R. and Robertson, G. R. (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol. 37, 206-213
16. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT) method. Methods 25, 402-408
17. Da Silva Morais, A., Lebrun, V., Abarca-Quinones, J., Brichard, S., Hue, L., Guigas, B., Viollet, B. and Leclercq, I. A. (2009) Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation. J. Hepatol. 50, 489-500
18. Mitchelhill, K. I., Stapleton, D., Gao, G., House, C., Michell, B., Katsis, F., Witters, L. A. and Kemp, B. E. (1994) Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 269, 2361-2364
19. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B. and Hue, L. (2006) 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874
20. Inoki, K., Zhu, T. and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590
21. Luo, Z., Saha, A. K., Xiang, X. and Ruderman, N. B. (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26, 69-76
22. Friedman, S. L. (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172
23. Imamura, M., Ogawa, T., Sasaguri, Y., Chayama, K. and Ueno, H. (2005) Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 128, 138-146
24. Knittel, T., Dinter, C., Kobold, D., Neubauer, K., Mehde, M., Eichhorst, S. and Ramadori, G. (1999) Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am. J. Pathol. 154, 153-167
25. Mahlapuu, M., Johansson, C., Lindgren, K., Hjalm, G., Barnes, B. R., Krook, A., Zierath, J. R., Andersson, L. and Marklund, S. (2004) Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 286, E194-E200
26. Sakamoto, K., Hirshman, M. F., Aschenbach, W. G. and Goodyear, L. J. (2002) Contraction regulation of Akt in rat skeletal muscle. J. Biol. Chem. 277, 11910-11917
27. Martin, K. A. and Blenis, J. (2002) Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv. Cancer Res. 86, 1-39
28. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E. and Shaw, R. J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226
29. Zhang, B. B., Zhou, G. and Li, C. (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9, 407-416
30. Nagata, D., Takeda, R., Sata, M., Satonaka, H., Suzuki, E., Nagano, T. and Hirata, Y. (2004) AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110, 444-451
31. Rattan, R., Giri, S., Singh, A. K. and Singh, I. (2005) 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J. Biol. Chem. 280, 39582-39593
32. Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K.,Woods, Y. L., McBurnie,W., Fleming, S. and Alessi, D. R. (2008) Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem. J. 412, 211-221
33. Mishra, R., Cool, B. L., Laderoute, K. R., Foretz, M., Viollet, B. and Simonson, M. S. (2008) AMP-activated protein kinase inhibits transforming growth factor-β-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J. Biol. Chem. 283, 10461-10469
34. Schnabl, B., Kweon, Y. O., Frederick, J. P., Wang, X. F., Rippe, R. A. and Brenner, D. A. (2001) The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34, 89-100